ForeverLabs
ServicesProvidersScienceMission
Schedule your free consultation

Regenerative Medicine Insights

Clinical trials, aesthetic applications, regulatory updates, research studies, and industry insights from the world of regenerative medicine

K

Latest Articles

Active Filters:
Tag: Parkinson Disease
AI generated image for: Adipose-derived mesenchymal stem cells (ADSCs) produces immediate changes in blood markers and muscle strength
Clinical
Dec 29, 2025
1 min read
Pubmed
Adipose-derived mesenchymal stem cells (ADSCs) produces immediate changes in blood markers and muscle strength
A 2025 prospective observational study tested whether a single administration of **adipose-derived mesenchymal stem cells (ADSCs)** produces immediate changes in blood markers and muscle strength in people with neurodegenerative and respiratory conditions. The study measured serum cholinesterase ...
Mesenchymal stem cellsCholinesteraseParkinson Disease

Stay in touch

Shop

Annual planLifetime PlanClient Login

Learn

ArticlesBlogFAQ

Careers

About usPrivacy PolicyPressTerms of Service

For Clinics

Scheduler LoginFor PhysiciansPartner With UsContact Us
ForeverLabs

Follow Us

FacebookXInstagramLinkedInYouTube

FDA and Stem Cell Therapies

The U.S. Food and Drug Administration (FDA) regulates stem cell therapies as biological products to ensure their safety and efficacy. The FDA requires that stem cell therapies undergo rigorous clinical trials to demonstrate safety and effectiveness before approval. Patients considering stem cell treatments should consult with their healthcare providers about FDA-approved options and be cautious of unproven therapies that have not undergone proper regulatory review.